NYSEAMERICAN:XTNT Xtant Medical (XTNT) Stock Price, News & Analysis $0.32 -0.01 (-2.14%) As of 09/18/2026 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsNews and TrendsOwnershipSEC Filings About Xtant Medical Stock (NYSEAMERICAN:XTNT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Xtant Medical alerts:Sign Up Key Stats Today's Range$0.32▼$0.3350-Day Range$0.31▼$0.4652-Week Range$0.27▼$0.95Volume199,290 shsAverage Volume4.96 million shsMarket Capitalization$44.89 millionP/E RatioN/ADividend YieldN/APrice Target$1.00Consensus RatingBuy Company Overview Xtant Medical Holdings, Inc. is a medical technology company focused on developing, manufacturing and marketing surgical products for spinal and orthopedic procedures. The company’s portfolio includes biologic products designed to support bone growth and tissue repair, as well as spinal implants and related surgical instruments. Its products are used by surgeons and hospitals in procedures involving spinal fusion, reconstruction and other orthopedic applications. Xtant’s biologics portfolio includes allograft and other regenerative solutions, while its hardware offerings include implants and instrumentation intended to support spinal stabilization and correction. Xtant Medical is headquartered in Belgrade, Montana, and primarily serves the U.S. healthcare market through a network of independent distributors, sales representatives and direct commercial activities. The company was formed through the combination of X-spine Systems and Bacterin International and has continued to expand its offerings in the spine and regenerative medicine markets.AI Generated. May Contain Errors. Read More Xtant Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks39th Percentile Overall ScoreXTNT MarketRank™: Xtant Medical scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingXtant Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and no sell ratings.Upside PotentialXtant Medical has a consensus price target of $1.00, representing about 212.5% upside from its current price of $0.32.Amount of Analyst CoverageXtant Medical has received no research coverage in the past 90 days.Read more about Xtant Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Xtant Medical is -4.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Xtant Medical is -4.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioXtant Medical has a P/B Ratio of 0.89. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Xtant Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.46% of the float of Xtant Medical has been sold short.Short Interest Ratio / Days to CoverXtant Medical has a short interest ratio ("days to cover") of 0.23, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Xtant Medical has recently increased by 1,667.80%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldXtant Medical does not currently pay a dividend.Dividend GrowthXtant Medical does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 1 people have searched for XTNT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Xtant Medical insiders have not sold or bought any company stock.Percentage Held by Insiders10.70% of the stock of Xtant Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions69.33% of the stock of Xtant Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Xtant Medical's insider trading history. Receive XTNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Xtant Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XTNT Stock News HeadlinesLucid Capital Markets initiates coverage of Xtant Medical Holdings (XTNT) with buy recommendationSeptember 3, 2026 | msn.comXtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental MarketAugust 27, 2026 | prnewswire.com$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its entire military budget. Central banks have bought over 1,000 tonnes of gold a year for three years running, trading paper for metal.September 20 at 1:00 AM | American Alternative (Ad)Xtant Medical (XTNT) Stock Forecast & Price TargetAugust 26, 2026 | investing.comXtant Medical Holdings (XTNT) Receives a Rating Update from a Top AnalystAugust 14, 2026 | theglobeandmail.comXtant Medical (XTNT) Q2 2026 Earnings Call TranscriptAugust 12, 2026 | finance.yahoo.comXtant Medical Holdings Corporate Event Calendar | AMEX:XTNTAugust 11, 2026 | benzinga.comXtant outlines $99M-$103M 2026 revenue guidance while integrating Dilon sales forceAugust 11, 2026 | seekingalpha.comSee More Headlines XTNT Stock Analysis - Frequently Asked Questions How have XTNT shares performed this year? Xtant Medical's stock was trading at $0.7840 at the beginning of 2026. Since then, XTNT shares have decreased by 59.2% and is now trading at $0.32. How were Xtant Medical's earnings last quarter? Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) issued its quarterly earnings results on Tuesday, August, 11th. The medical device company reported ($0.07) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.05. The medical device company had revenue of $23.03 million for the quarter, compared to analyst estimates of $24.88 million. Xtant Medical had a negative net margin of 10.17% and a negative trailing twelve-month return on equity of 23.45%. Read the conference call transcript. When did Xtant Medical's stock split? Xtant Medical shares reverse split on Wednesday, February 14th 2018.The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. Who are Xtant Medical's major shareholders? Xtant Medical's top institutional shareholders include AWM Investment Company Inc. (4.26%). View institutional ownership trends. How do I buy shares of Xtant Medical? Shares of XTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Xtant Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Xtant Medical investors own include Meta Platforms (META), Aurinia Pharmaceuticals (AUPH), NVIDIA (NVDA), Alibaba Group (BABA), Tesla (TSLA) and Broadcom (AVGO). Company Calendar Last Earnings8/11/2026Today9/20/2026Next Earnings (Estimated)11/10/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 XTNT's financial health is in the Red zone, according to TradeSmith. XTNT has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSEAMERICAN:XTNT Previous SymbolAMEX:XTNT CIK1453593 Webxtantmedical.com Phone(406) 388-0480Fax406-388-1354Employees151Year Founded2006Price Target and Rating Average Price Target for Xtant Medical$1.00 High Price Target$1.00 Low Price Target$1.00 Potential Upside/Downside+212.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($0.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$4.97 million Net Margins-10.17% Pretax Margin-8.44% Return on Equity-23.45% Return on Assets-12.44% Debt Debt-to-Equity Ratio0.18 Current Ratio2.16 Quick Ratio1.05 Sales & Book Value Annual Sales$133.93 million Price / Sales0.34 Cash Flow$0.07 per share Price / Cash Flow4.39 Book Value$0.36 per share Price / Book0.89Miscellaneous Outstanding Shares140,290,000Free Float125,277,000Market Cap$44.89 million OptionableNot Optionable Beta-0.15 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSEAMERICAN:XTNT) was last updated on 9/20/2026 by MarketBeat.com Staff. From Our Partners$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | Sponsored“Elon’s nightmare” could fund your retirementMarc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredYou’ve never seen anything like this beforeFor centuries, families like the Rothschilds, Morgans, and Rockefellers have quietly used one overlooked type ...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredNVDA CEO says it’s a "once-in-a-generation opportunity"NVIDIA CEO Jensen Huang calls a little-known AI niche a once-in-a-generation opportunity, and it has nothing t...Monument Traders Alliance | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xtant Medical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xtant Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
